Bio-Techne (TECH) Share-based Compensation Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 279.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 279.93% |
| Dec 31, 2025 | -68.63% |
| Sep 30, 2025 | -6.87% |
| Jun 30, 2025 | -18.50% |
| Mar 31, 2025 | -64.65% |
| Dec 31, 2024 | 236.48% |
| Sep 30, 2024 | -4.62% |
| Jun 30, 2024 | -17.70% |
| Mar 31, 2024 | 172.57% |
| Dec 31, 2023 | -73.21% |
| Sep 30, 2023 | -7.98% |
| Jun 30, 2023 | -32.88% |
| Mar 31, 2023 | -70.87% |
| Dec 31, 2022 | 15.12% |
| Sep 30, 2022 | 18.01% |
| Jun 30, 2022 | 1.12% |
| Mar 31, 2022 | 16.52% |
| Dec 31, 2021 | -61.30% |
| Sep 30, 2021 | 0.49% |
| Jun 30, 2021 | -4.73% |
| Mar 31, 2021 | -56.01% |
| Dec 31, 2020 | 46.12% |
| Sep 30, 2020 | 50.56% |
| Jun 30, 2020 | 20.82% |
| Mar 31, 2020 | 26.73% |
| Dec 31, 2019 | 37.33% |
| Sep 30, 2019 | 40.25% |
| Jun 30, 2019 | 43.45% |
| Mar 31, 2019 | 35.19% |
| Dec 31, 2018 | 43.79% |
| Sep 30, 2018 | 78.37% |
| Jun 30, 2018 | 128.26% |
| Mar 31, 2018 | 53.96% |
| Dec 31, 2017 | 34.07% |
| Sep 30, 2017 | 40.72% |
| Jun 30, 2017 | 56.63% |
| Mar 31, 2017 | 78.39% |
| Dec 31, 2016 | 46.65% |
| Sep 30, 2016 | 77.65% |
| Jun 30, 2016 | 77.80% |
| Mar 31, 2016 | 100.84% |
| Dec 31, 2015 | 43.53% |
| Sep 30, 2015 | 88.76% |
| Jun 30, 2015 | 69.72% |
| Mar 31, 2015 | 74.84% |
| Dec 31, 2014 | 34.23% |
| Sep 30, 2014 | 67.47% |
| Jun 30, 2014 | 64.09% |
| Mar 31, 2014 | 100.38% |
| Dec 31, 2013 | 22.11% |
| Sep 30, 2013 | 61.14% |
| Jun 30, 2013 | 40.95% |
| Mar 31, 2013 | 52.27% |
| Dec 31, 2012 | 0.34% |
| Sep 30, 2012 | 43.75% |